9 Heart Attack Clinical Trials in Middletown, CT (2026)

Q: How do I join a clinical trial in Middletown?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Middletown research site will contact you.

Recruiting Heart Attack Studies in Middletown

NCT03824483Recruiting

Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)

The purpose of this study is to determine the rate of minimum residual disease (MRD) negative response (i.e. the rate of no evidence of disease) of the study drugs, zanubrutinib, obinutuzumab, and ven...

Middletown, CT230 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05640843Recruiting

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

The researchers are doing this study to look at how butyrate levels change in participants' stool after they are on a- plant-based diet for at least 12 weeks. All participants will have monoclonal gam...

Middletown, CT180 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06698003Recruiting

A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

The purpose of this study is to find out whether the study drug mogamulizumab is effective in preventing the development of adult T-cell leukemia/lymphoma (ATL) in people who are at higher risk for th...

Middletown, CT134 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06561360Recruiting

A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People with Hairy Cell Leukemia (HCL)

The researchers are doing this study to compare the safety of vemurafenib in combination with obinutuzumab to the standard of approach of cladribine in combination with rituximab. The researchers will...

Middletown, CT86 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07356154Recruiting

A Study of Revumenib and Mezigdomide in People With Leukemia

The purpose of this study is to find out whether the combination of mezigdomide and revumenib is a safe treatment for people with relapsed or refractory KMT2A-r, NUP98-r, and NPM1-m acute leukemias....

Middletown, CT52 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07392242Recruiting

A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

The researchers are doing this study to find out whether a 3-drug combination of ivosidenib, azacitidine, and venetoclax followed by maintenance therapy with ivosidenib alone is an effective treatment...

Middletown, CT45 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05354570Recruiting

A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and Chest

The researchers are doing this study to find out whether hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) is a safe treatment that causes few or mild side effects in people with pl...

Middletown, CT36 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06773208Recruiting

A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

The purpose of this study is to find out if azacitidine and venetoclax are an effective treatment approach to get rid of or lower measurable residual disease (MRD) in people with acute myeloid leukemi...

Middletown, CT30 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06017258Recruiting

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

The purpose of this study is to find out whether CD371-YSNVZ-IL18 CAR T cells are safe, and to look for the highest dose of CD371-YSNVZ-IL18 CAR T cells that cause few or mild side effects in particip...

Middletown, CT15 participantsMemorial Sloan Kettering Cancer Center

View Study Details

About Heart Attack Clinical Trials in Middletown

A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.

There are currently 9 heart attack clinical trials recruiting participants in Middletown, CT. These studies are seeking a combined 808 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Attack Clinical Trials in Middletown — FAQ

Are there heart attack clinical trials in Middletown?

Yes, there are 9 heart attack clinical trials currently recruiting in Middletown, CT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Middletown?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Middletown research site will contact you about next steps.

Are clinical trials in Middletown free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Middletown studies also compensate for your time and travel.

What heart attack treatments are being tested?

The 9 active trials in Middletown are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.

Data updated July 13, 2026 from ClinicalTrials.gov